Literature DB >> 15979068

Differential effects of amphiregulin and TGF-alpha on the morphology of MDCK cells.

Eunkyung Chung1, Ramona Graves-Deal, Jeffrey L Franklin, Robert J Coffey.   

Abstract

Although both amphiregulin and TGF-alpha are known to exert their effects through the EGF receptor, we find that concentrations of recombinant human amphiregulin and TGF-alpha that are equipotent in EGF receptor activation and mitogenesis exhibit markedly different effects on MDCK cell morphology. Amphiregulin induces a spindle-like morphology that is associated with a redistribution of E-cadherin from a Triton-insoluble to Triton-soluble pool. TGF-alpha does not affect epithelial morphology nor does it affect the distribution of the Triton-soluble or -insoluble pool of E-cadherin. The effects of amphiregulin on E-cadherin are associated with actin rearrangement. The morphological and biochemical effects of amphiregulin are prevented by EGF receptor blockade but require Src-family kinase activity and MAPK signaling. These results identify an action of amphiregulin that is distinct from TGF-alpha that may contribute to amphiregulin's participation in the pathogenesis of inflammatory disorders like psoriasis and cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979068     DOI: 10.1016/j.yexcr.2005.05.012

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

1.  Amphiregulin exosomes increase cancer cell invasion.

Authors:  James N Higginbotham; Michelle Demory Beckler; Jonathan D Gephart; Jeffrey L Franklin; Galina Bogatcheva; Gert-Jan Kremers; David W Piston; Gregory D Ayers; Russell E McConnell; Matthew J Tyska; Robert J Coffey
Journal:  Curr Biol       Date:  2011-04-21       Impact factor: 10.834

2.  Myristoylated Naked2 antagonizes Wnt-beta-catenin activity by degrading Dishevelled-1 at the plasma membrane.

Authors:  Tianhui Hu; Cunxi Li; Zheng Cao; Terence J Van Raay; Jason G Smith; Karl Willert; Lila Solnica-Krezel; Robert J Coffey
Journal:  J Biol Chem       Date:  2010-02-20       Impact factor: 5.157

3.  Alterations of gene expression in the development of early hyperplastic precursors of breast cancer.

Authors:  Sangjun Lee; Dan Medina; Anna Tsimelzon; Syed K Mohsin; Sufeng Mao; Yun Wu; D Craig Allred
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 4.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

5.  The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.

Authors:  Kristy J Wilson; Christopher P Mill; Richard M Gallo; Elizabeth M Cameron; Henry VanBrocklin; Jeffrey Settleman; David J Riese
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

6.  A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo.

Authors:  Yu-Ping Yang; Haiting Ma; Alina Starchenko; Won Jae Huh; Wei Li; F Edward Hickman; Qin Zhang; Jeffrey L Franklin; Douglas P Mortlock; Sabine Fuhrmann; Bruce D Carter; Rebecca A Ihrie; Robert J Coffey
Journal:  Cell Rep       Date:  2017-05-09       Impact factor: 9.423

7.  Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.

Authors:  Michelle Demory Beckler; James N Higginbotham; Jeffrey L Franklin; Amy-Joan Ham; Patrick J Halvey; Imade E Imasuen; Corbin Whitwell; Ming Li; Daniel C Liebler; Robert J Coffey
Journal:  Mol Cell Proteomics       Date:  2012-11-15       Impact factor: 5.911

Review 8.  At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone.

Authors:  John Foley; Nicole Nickerson; David J Riese; Peter C Hollenhorst; Gwendolen Lorch; Anne M Foley
Journal:  Odontology       Date:  2012-06-10       Impact factor: 2.634

9.  TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.

Authors:  Nipun B Merchant; Igor Voskresensky; Christopher M Rogers; Bonnie Lafleur; Peter J Dempsey; Ramona Graves-Deal; Frank Revetta; A Coe Foutch; Mace L Rothenberg; Mary K Washington; Robert J Coffey
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

10.  Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.

Authors:  Jennifer L Gilmore; Jeffrey A Scott; Zhor Bouizar; Alex Robling; Sarah E Pitfield; David J Riese; John Foley
Journal:  Breast Cancer Res Treat       Date:  2007-09-20       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.